The Global Beta
Glucan Based Products Market, by Source (Cereals, Yeast, Mushroom, and
Others), by Grade (Pharma, Medical, Food, Cosmetics, Enhanced Oil Recovery
(EOR), and Animal Feed), and by Region (North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa), was valued at US$ 486.4 million in 2018
and is projected to exhibit a CAGR of 7.2% during the forecast period (2018 -
2026).
Beta glucans have been the
subject of intensifying research, owing to its beneficial role in lowering
insulin resistance and blood cholesterol, reducing the risk of obesity, and boosting
the immune system to fight cancer. Moreover, various health regulatory bodies
have approved beta glucan–containing foods to lower blood cholesterol levels by
5% to 8%. These allow various key
players in the market to operate in beta glucan based products market and gain
significant market share. For instance, in April 2019, Lantmännen acquired the
oat ingredients business based in Kimstad, Sweden from Tate & Lyle.
Moreover, Lantmännen’s acquisition of a Tate & Lyle’s mill and production
facility for processing of oats in Kimstad will strengthen Lantmännen’s
position in the oats market. In
November 2017, Naturex (now a subsidiary of Givaudan) acquired Swedish Oat
Fiber, a specialized Sweden-based manufacturer with key international presence as
a producer of oat beta glucans dietary fibers, oat oils, and oat proteins,
addressing food industry, nutraceutical, cosmetic, and animal feed
applications. In December 2014, Leica Biosystems, a global leader in anatomic
pathology laboratory solutions and instruments and subsidiary of Danaher
Corporation, acquired Devicor Medical Products, Inc.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2597
In October 2014, NutraQ announced
that it entered into a distribution partnership with American International
Chemical LLC (AIC) to exclusively distribute the NBG range of beta-glucans in
the U.S., Canada, and Mexico.
Browse 32 Market Data Tables and
30 Figures spread through 244 Pages and in-depth TOC on "Beta Glucan Based
Products Market, by Source (Cereals, Yeast, Mushroom, and Others), by Grade
(Pharma, Medical, Food, Cosmetics, Enhanced Oil Recovery (EOR), and Animal
Feed), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) - Global Forecast to 2026"
Furthermore, the introduction of
regulations and gradually increasing research have resulted in increasing
application areas of yeast Beta Glucan and increasing market size. Health
claims for beta glucan containing foods have been allowed in the U.S., Canada,
Sweden, Finland, and the U.K. since 2006. The health claims approved by the FDA
and the European Food Safety Authority (EFSA) are based on research showing
that consuming 3 g of beta-glucans per day, from either oats or barley, can
lower blood cholesterol levels by 6% to 8%. In May 2016, the FDA announced a
new regulatory definition for dietary fiber and stated that to be considered a
source of fiber, isolated or synthetic non-digestible carbohydrates must have a
demonstrated physiological health benefit. Products that contain at least 0.75
grams of beta-glucan per serving may use the FDA health claim: ‘Soluble fiber
from foods such as oats, as part of a diet low in saturated fat and
cholesterol, may reduce the risk of heart disease’.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/beta-glucan-based-products-market-2597
Key Takeaways of the Beta Glucan
Based Products Market:
The global beta glucan based
products market is expected to witness a CAGR of 4.1% during the forecast
period (2018 – 2026), owing to increasing engagement of key players in this
market
Among source, the yeast segment
accounted for major market share in 2017. Yeast derived beta glucan is one of
the major products in the market with wide applications in management of high
cholesterol levels and diabetes, and boosting immune system. This segment is
expected to witness significant growth over the forecast period, owing to
increasing awareness about immunity booster ingredients.
Among grade, pharma segment held
major market share in 2017. Beta glucan based products are extensively utilized
in pharma grade products such as health supplements powder, capsules, and
tablets. Oat and barley are very rich sources of beta glucans, which shows
immunity modulator effect. Due to its immunity modulator effect, the pharma
grade beta glucans are expected to drive growth of the pharma segment over the
forecast period.
Some of the major players
operating in the global beta glucan based products market include Jkosmmune,
Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke
DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd.,
Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd.,
Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies,
Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc., and AIPPO
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2597
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment